Gilead Sciences EuroCharity's RSS for Gilead Sciences en 2010 5th Wednesday of August 2020 10:52:19 PM 5th Wednesday of August 2020 10:52:19 PM en 2010 Logo Gilead: U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma Kite Becomes First Company with Multiple Approved CAR T Therapies 2020-07-27 11:07:34 15575 2010-03-23T15:57:28Z Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million Gilead Research and Development Funding to Accelerate Tizona’s First-in-Class Pipeline 2020-07-27 11:07:32 15576 2010-03-23T15:57:28Z Gilead Sciences: Taking Care of Those Who Are Left Out and Left Behind Read the article written by Rashad Burgess, Executive Director of HIV Community Operations at Gilead 2020-07-01 14:07:23 15541 2010-03-23T15:57:28Z An Open Letter from Daniel O’Day, Chairman & CEO, Gilead Sciences After receiving the green light from the FDA to move forward, Gilead is about to start trials of an inhaled version of remdesivi 2020-06-29 14:06:13 15533 2010-03-23T15:57:28Z Gilead Sciences: Volunteering on the Front Lines: Gilead Employee, Physician Goes to Work at UK Hospital Shayon is one of several Gilead employees with medical backgrounds who have answered the call for volunteers to help health systems handle the challenges presented by COVID-19 2020-06-11 16:06:37 15479 2010-03-23T15:57:28Z